Posted by Michael Wonder on 20 Oct 2022
Ireland’s cancer survival rates lag behind other EU countries with access to new drugs ‘limited’
20 October 2022 - Patient access to newer cancer medicines is limited and comes later in Ireland compared to other EU countries, except Portugal, as our survival rates for the disease continue to lag behind the best performers, a new analysis shows today.
Between 2012 and 2020, 10 new cancer medicines annually were approved by the EMA.
